Pain News and Research

Latest Pain News and Research

Genentech receives FDA approval for Lucentis to treat diabetic macular edema

Genentech, a member of the Roche Group, today announced that Lucentis (ranibizumab injection) was approved by the U.S. Food & Drug Administration (FDA) for treatment of diabetic macular edema (DME), an eye condition in people with diabetes that causes blurred vision, severe vision loss and sometimes blindness

12 Aug 2012

Lucentis receives FDA approval for treatment of diabetic macular edema

The U.S. Food and Drug Administration today approved Lucentis (ranibizumab injection) for the treatment of diabetic macular edema (DME), a sight-threatening eye disease that occurs in people with diabetes.

10 Aug 2012

Fat transfers may benefit patients after breast reconstructive surgery

When Susan McLain, 49, underwent a double mastectomy, she never imagined that she would look and feel better after reconstructive surgery than she did before breast cancer.

10 Aug 2012

Health insurer rebates: Where has the money gone?

The New York Times reports that many consumers who get health coverage through their employers wonder what happened to the insurer rebates that were part of "the great health insurance giveback" under the health law. Also in the news, The Associated Press details who will be hit the hardest by the health law's tax provisions.

10 Aug 2012

Doctors may underestimate importance of small set of risks that vex patients

Most informed consent disputes involve disagreements about who said what and when, not stand-offs over whether a particular risk ought to have been disclosed. But doctors may "routinely underestimate the importance of a small set of risks that vex patients" according to international experts writing in this week's PLOS Medicine.

10 Aug 2012

First Edition: August 10, 2012

Reporting for Kaiser Health News, in collaboration with The Washington Post, Susan Jaffe writes: "Concerned that a growing number of seniors have been unexpectedly forced to pay thousands of dollars for nursing home care after a stay in a hospital, Medicare has launched a pilot project to test whether relaxing its hospital payment rules could help beneficiaries".

10 Aug 2012

IRIN examines administration of methadone as treatment for people who inject drugs in Bangladesh

"Methadone treatment is proving to be the most efficient way to wean people in Bangladesh from addiction to buprenorphine, a pharmaceutical drug, and health experts say it should be expanded to reach thousands more drug users to prevent the spread of HIV," IRIN reports.

10 Aug 2012

Depressed patients at risk of developing peripheral artery disease

Depression was linked with an increased risk of peripheral artery disease (PAD) in a study of more than one thousand men and women with heart disease conducted by researchers at the San Francisco VA Medical Center and the University of California, San Francisco.

10 Aug 2012

Depressed cardiac patients at added risk

Coronary artery disease patients may have an increased risk for peripheral arterial disease if they are depressed, study findings show.

10 Aug 2012

$Thoracolumbar vertebrae fracture may be ‘silent’$

Thoracolumbar vertebrae fracture may be ‘silent’

Imaging is essential to avoid missing fractures to the thoracolumbar vertebrae in patients who have sustained blunt injury, UK researchers say.

10 Aug 2012

Trauma: spending more money doesn’t translate to higher survival rates

A large-scale review of national patient records reveals that although survival rates are the same, the cost of treating trauma patients in the western United States is 33 percent higher than the bill for treating similarly injured patients in the Northeast. Overall, treatment costs were lower in the Northeast than anywhere in the United States.

10 Aug 2012

Patient cognition may affect EOL care intensity

Mild cognitive impairment in patients with advanced cancer may affect the intensity of end-of-life treatment and promote decision-making by caregivers, rather than patients, show US study results.

9 Aug 2012

Recurrences of ovarian cancer can be detected earlier and more accurately with PET/CT

Due to the lack of studies, there is currently no proof that patients with ovarian cancer can benefit from positron emission tomography (PET) alone or in combination with computed tomography (CT). As regards diagnostic accuracy, in certain cases, recurrences can be detected earlier and more accurately with PET or PET/CT than with conventional imaging techniques.

9 Aug 2012

Doctors sometimes fail to warn patients of particular risks before treatment

Australian doctors sometimes fail to warn patients of risks that could affect the patient's quality of life before providing treatment or surgery, a new study led by University of Melbourne researchers has shown.

9 Aug 2012

CardioDx establishes coverage for Corus CAD gene expression test

CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced that Palmetto GBA, a national contractor that administers Medicare benefits, has established coverage for the company's Corus CAD gene expression test for the evaluation of patients presenting with typical and atypical symptoms suggestive of coronary artery disease.

9 Aug 2012

Educational programs, increased physician collaboration can reduce inappropriate CCTA use

Appropriate use of testing is a hot topic in medicine as physicians and hospitals look for ways to improve quality while containing cost to achieve high-value care. This is especially true in the field of cardiology where the potential consequences of incorrect diagnosis have led to overuse of cardiovascular imaging with CT scanners, called coronary CT angiography.

9 Aug 2012

One third of all post-partum women exhibit some symptoms of PTSD

Post-Traumatic Stress Disorder (PTSD) develops in individuals who experience highly traumatizing situations such as terrorist attacks and car accidents, but symptoms can also come about after normal life events - including childbirth.

9 Aug 2012

Alfa Wassermann, Salix enter license agreement for EIR formulation of rifaximin

Salix Pharmaceuticals, Ltd. and Alfa Wassermann S.p.A. today announced that they have entered into an exclusive agreement by which Salix has licensed rights in the United States and Canada to an extended intestinal release (EIR) formulation of rifaximin for gastrointestinal and respiratory indications, including Crohn's disease.

9 Aug 2012

Active Biotech, Teva to commence third Phase III study of laquinimod for RRMS

Teva Pharmaceutical Industries Ltd. and Active Biotech provided today an update on the clinical development program of once-daily oral laquinimod for the treatment of relapsing-remitting multiple sclerosis (RRMS).

9 Aug 2012

Vulvodynia confers risk for other chronic pain syndromes

Women who experience vulvodynia are more likely than those without the pain syndrome to have fibromyalgia, interstitial cystitis, and irritable bowel syndrome, research suggests.

8 Aug 2012